About this trial

Magnetic resonance imaging (MRI), as a non-invasive and non-contrast enhanced technique, has the potential to improve patient health care and management. The overall objective of proposed project is to:

1. develop, customize, and optimize anatomic and functional MRI methods, 2. explore the use of MRI methods to study CKD and evaluate post-transplant kidneys, and 3. investigate the potential of MRI in the diagnosis, prognosis, and monitoring of the progression of renal dysfunction.

In addition to direct studies of the kidney, brain MRI studies will also be performed to identify the cerebrovascular and cognitive effects of chronic renal function deficiency and medical treatment (e.g. hemodialysis and immunosuppression). The brain and kidneys have similar vascular bed, and both are susceptible to vascular injury, which provides the pathological basis for the widely recognized association of reduced renal function with prevalent cerebrovascular diseases (CVDs) and cognitive impairment (CI). The MRI methods in the brain will be applied to explore the origins for widely observed CVDs and prevalent cognitive impairment (CI) in kidney disease patients.

Eligibility criteria

Qualifiers

None

Disqualifiers

Ferromagnetic implants

Any foreign metal objects in the body

History of shrapnel or shot gun injury

Cardiac pacemakers

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

180 Participants
are grouped into 5 trial groups

Locations

1
Center for Magnetic Resonance Research55455, MinneapolisMinnesota, United States

Sponsors and collaborators

University of Minnesota

Lead sponsor